The global production of Abacavir Sulfate Active Pharmaceutical Ingredient (API) is served by a relatively limited number of focused manufacturers. Several companies across regions like China and the United States hold significant percentages in this vital segment of the pharmaceutical sector. Conformance is of the highest importance, necessitating